Namodenoson (CF102) Cancer - advanced liver cancer phase 2 results in Q1 2019 (in few weeks)
Very risky
Very risky
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.